Detalhe da pesquisa
1.
Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children.
Allergy
; 73(12): 2352-2363, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043449
2.
Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial.
Allergol Int
; 67(3): 347-356, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29233461
3.
Dual sublingual immunotherapy with Japanese Cedar Pollen droplets and House Dust Mite tablets.
Allergol Int
; 68(4): 533-535, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962053
4.
[Developmental history of sublingual immunotherapy].
Nihon Yakurigaku Zasshi
; 154(1): 6-11, 2019.
Artigo
em Japonês
| MEDLINE | ID: mdl-31308350